154 related articles for article (PubMed ID: 15811592)
21. Rotenone induces aggregation of gamma-tubulin protein and subsequent disorganization of the centrosome: relevance to formation of inclusion bodies and neurodegeneration.
Diaz-Corrales FJ; Asanuma M; Miyazaki I; Miyoshi K; Ogawa N
Neuroscience; 2005; 133(1):117-35. PubMed ID: 15893636
[TBL] [Abstract][Full Text] [Related]
22. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
[TBL] [Abstract][Full Text] [Related]
23. Abnormalities of the nucleus and nuclear inclusions in neurodegenerative disease: a work in progress.
Woulfe JM
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):2-42. PubMed ID: 17239006
[TBL] [Abstract][Full Text] [Related]
24. Ubiquitin-proteasome system dysfunction in Parkinson's disease: current evidence and controversies.
Lim KL
Expert Rev Proteomics; 2007 Dec; 4(6):769-81. PubMed ID: 18067415
[TBL] [Abstract][Full Text] [Related]
25. The neuronal ubiquitin-proteasome system: murine models and their neurological phenotype.
van Tijn P; Hol EM; van Leeuwen FW; Fischer DF
Prog Neurobiol; 2008 Jun; 85(2):176-93. PubMed ID: 18448229
[TBL] [Abstract][Full Text] [Related]
26. Role of polyunsaturated fatty acids for misfolding protein aggregations: implication for neurodegenerative diseases.
Kim YJ; Takahashi R
Ann N Y Acad Sci; 2006 Nov; 1086():11-20. PubMed ID: 17185502
[TBL] [Abstract][Full Text] [Related]
27. Application of ubiquitin immunohistochemistry to the diagnosis of disease.
Lowe J; Hand N; Mayer RJ
Methods Enzymol; 2005; 399():86-119. PubMed ID: 16338351
[TBL] [Abstract][Full Text] [Related]
28. Overstimulation of the alpha1B-adrenergic receptor causes a "seizure plus" syndrome.
Seppi K; Puschban Z; Stefanova N; Scherfler C; Mueller J; Poewe W; Wenning GK
Nat Med; 2001 Feb; 7(2):132. PubMed ID: 11175818
[No Abstract] [Full Text] [Related]
29. What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease?
Armstrong RA; Lantos PL; Cairns NJ
Neuropathology; 2008 Aug; 28(4):351-65. PubMed ID: 18433435
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
Chalmers KA; Love S
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
[TBL] [Abstract][Full Text] [Related]
31. Protein homeostasis in neurons and its pathological alterations.
Malgaroli A; Vallar L; Zimarino V
Curr Opin Neurobiol; 2006 Jun; 16(3):270-4. PubMed ID: 16713705
[TBL] [Abstract][Full Text] [Related]
32. Selective loss of dopaminergic neurons and formation of Lewy body-like aggregations in alpha-synuclein transgenic fly neuronal cultures.
Park SS; Lee D
Eur J Neurosci; 2006 Jun; 23(11):2908-14. PubMed ID: 16819979
[TBL] [Abstract][Full Text] [Related]
33. Protein ubiquitination, degradation and the proteasome in neuro-degenerative disorders: no clear evidence for a significant pathogenetic role of proteasome failure in Alzheimer disease and related disorders.
Schmitt HP
Med Hypotheses; 2006; 67(2):311-7. PubMed ID: 16580788
[TBL] [Abstract][Full Text] [Related]
34. Protein aggregation mechanisms in synucleinopathies: commonalities and differences.
Beyer K; Ariza A
J Neuropathol Exp Neurol; 2007 Nov; 66(11):965-74. PubMed ID: 17984679
[TBL] [Abstract][Full Text] [Related]
35. Analysis of single, purified inclusions as a novel approach to understand methamphetamine neurotoxicity.
Lenzi P; Fulceri F; Lazzeri G; Casini A; Ruggieri S; Paparelli A; Fornai F
Ann N Y Acad Sci; 2008 Oct; 1139():186-90. PubMed ID: 18991863
[TBL] [Abstract][Full Text] [Related]
36. The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B+1.
Hol EM; van Leeuwen FW; Fischer DF
Trends Mol Med; 2005 Nov; 11(11):488-95. PubMed ID: 16213790
[TBL] [Abstract][Full Text] [Related]
37. In PC12 cells neurotoxicity induced by methamphetamine is related to proteasome inhibition.
Lazzeri G; Lenzi P; Gesi M; Ferrucci M; Fulceri F; Ruggieri S; Bruno V; Fornai F
Ann N Y Acad Sci; 2006 Aug; 1074():174-7. PubMed ID: 17105915
[TBL] [Abstract][Full Text] [Related]
38. SUMO-1 marks subdomains within glial cytoplasmic inclusions of multiple system atrophy.
Pountney DL; Chegini F; Shen X; Blumbergs PC; Gai WP
Neurosci Lett; 2005 Jun 10-17; 381(1-2):74-9. PubMed ID: 15882793
[TBL] [Abstract][Full Text] [Related]
39. Frontotemporal lobar degeneration with ubiquitin-positive inclusions: a molecular genetic update.
van der Zee J; Gijselinck I; Pirici D; Kumar-Singh S; Cruts M; Van Broeckhoven C
Neurodegener Dis; 2007; 4(2-3):227-35. PubMed ID: 17596717
[TBL] [Abstract][Full Text] [Related]
40. Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease.
Takeda T; Uchihara T; Arai N; Mizutani T; Iwata M
Acta Neuropathol; 2009 Jan; 117(1):35-44. PubMed ID: 19002475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]